We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App





World's First Urinary Catheter Stabilizer That Actively Prevents Accidental Extractions Introduced at MEDICA 2021

By HospiMedica International staff writers
Posted on 15 Nov 2021

CATHETRIX (Tel-Aviv, Israel) presented its new catheter stabilizer for the prevention of urinary tract infections (UTI) and accidental Foley catheter extractions at MEDICA 2021, which took place November 15–18 in Dusseldorf, Germany. More...

CATHETRIX’s new Foley/Safe 2.0 Catheter Securement Device is the world’s first Foley catheter stabilizer that actively prevents accidental extractions. Foley/Safe 2.0 prevents catheter dislodgement and movement to reduce the risk of catheter associated UTI. The innovative catheter stabilizer prevents unintentional and accidental urinary catheter extraction, thus avoiding damage and strictures to the bladder or urethra. Once the Foley catheter is pulled with a force that can harm the patient, Foley/Safe 2.0 will cut the sterile fluid tube and let the retention balloon deflate, permitting the catheter to slide out safely. Foley/Safe 2.0 provides two-layer protection securement to patients with Foley catheters, latex and silicone.

Medical studies have shown that 11-17% of all catheters are unintentionally extracted and 5% of all urological catheters are traumatically pulled out. Some 25% of all hospitalized patients, as well as people confined to bed in hospices and nursing homes, have urinary catheters. Many of these inpatients tend to dislodge their catheter tube, thereby causing themselves unnecessary pain, injury and increased risk of damage and infections. Foley/Safe safely prevents surgery and expensive hospitalization. The device has been patented and has received US FDA and EU CE Mark clearances.

Related Links:
CATHETRIX 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Hemostatic Agent
HEMOBLAST Bellows
New
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.